Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties
Federica Costa(University of Parma), Nicola Giuliani(University of Parma)
Cited by 30
Related Papers
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target
|Blood|2016|172
Checkpoint Inhibition in Myeloma: Opportunities and Challenges
|Frontiers in Immunology|2018|62